N4 Pharma (LON:N4P) Shares Down 12%

N4 Pharma Plc (LON:N4PGet Free Report)’s share price fell 12% on Friday . The stock traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.55 ($0.01). 1,193,020 shares traded hands during trading, an increase of 12% from the average session volume of 1,061,330 shares. The stock had previously closed at GBX 0.63 ($0.01).

N4 Pharma Stock Performance

The stock has a fifty day moving average price of GBX 0.75 and a two-hundred day moving average price of GBX 0.80. The company has a market capitalization of £1.37 million, a price-to-earnings ratio of -65.00 and a beta of -0.07. The company has a quick ratio of 7.28, a current ratio of 14.86 and a debt-to-equity ratio of 1.62.

About N4 Pharma

(Get Free Report)

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Recommended Stories

Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.